Preliminary phase 1 results of U3-1402: A novel HER3-targeted antibody-drug conjugate-in EGFR TKI-resistant, EGFR-mutant NSCLC Meeting Abstract
| Authors: | Yu, H.; Johnson, M.; Steuer, C.; Vigliotti, M.; Chen, S.; Kamai, Y.; Yu, C.; Janne, P. |
| Abstract Title: | Preliminary phase 1 results of U3-1402: A novel HER3-targeted antibody-drug conjugate-in EGFR TKI-resistant, EGFR-mutant NSCLC |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | antibody drug conjugate; u3-1402; egfr tki-resistant nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S336 |
| End Page: | S337 |
| Language: | English |
| ACCESSION: | WOS:000492162202006 |
| DOI: | 10.1016/j.jtho.2019.08.677 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: MA21.06 -- Source: Wos |
